Scandinavian Biopharma
Erik Tingborn is a senior scientist at Scandinavian Biopharma, with extensive experience in biopharmaceuticals and analytical techniques. Previous roles include scientist at Xbrane Biopharma AB, where Erik introduced new analytical techniques and contributed to key aspects of the marketing authorization application for a ranibizumab biosimilar. Experience as a life sciences consultant at agap2 Sweden involved supporting downstream applications for viral vectors, while earlier positions included IT consulting and method development for major biopharmaceutical organizations. Erik also gained foundational experience through a master's thesis focused on ITP-ESI-MS system development at KTH Royal Institute of Technology, where Erik completed a degree from 2011 to 2016.
This person is not in any teams
Scandinavian Biopharma
We are a research-based specialty biopharma company determined to give people all over the world a longer and better life. We are developing the first vaccine for protection against diarrhoea caused by ETEC in both travellers and endemic populations. We distribute a wide range of specialty biopharma products with focus on vaccines and immunoglobulins.